|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and amounts due from depository institutions | ||||||||||||||||||||
| Interest-bearing deposits in other banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities available for sale (amortized cost of $1,060,864 and $1,125,111, respectively), net of allowance for credit losses of $0 at June 30, 2026 and June 30, 2025 | ||||||||||||||||||||
| Investment securities held to maturity (fair value of $95,005 and $106,712, respectively), net of allowance for credit losses of $0 at June 30, 2026 and June 30, 2025 | ||||||||||||||||||||
| Loans held-for-sale | ||||||||||||||||||||
| Loans receivable | ||||||||||||||||||||
| Less: allowance for credit losses on loans | ||||||||||||||||||||
| Net loans receivable | ||||||||||||||||||||
| Premises and equipment | ||||||||||||||||||||
| Federal Home Loan Bank ("FHLB") of New York stock | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangibles | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Deferred income tax assets, net | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Non-interest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Advance payments by borrowers for taxes | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred stock, outstanding (in shares) | ||||||||||||||||||||
| Preferred stock, issued (in shares) | ||||||||||||||||||||
| Preferred stock, authorized (in shares) | ||||||||||||||||||||
| Preferred stock, par value (in dollars per share) | ||||||||||||||||||||
| Common stock, authorized (in shares) | ||||||||||||||||||||
| Common stock, outstanding (in shares) | ||||||||||||||||||||
| Common stock, issued (in shares) | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 100,000,000 shares authorized; none issued and outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value; 800,000,000 shares authorized; 64,738,125 shares and 64,577,481 shares issued and outstanding, respectively | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Unearned employee stock ownership plan (in shares) | ||||||||||||||||||||
| Unearned employee stock ownership plan shares;1,756,107 shares and 1,956,805 shares, respectively | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
